Comparison Between Turquoise and Blue Light in Treatment of Neonatal Jaundice Using Light Emission Diodes

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Uncomplicated Neonatal Hyperbilirubinemia

Treatments

Other: Phototherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02154165
PKV 2013

Details and patient eligibility

About

The optimal wavelength for phototherapy for neonatal jaundice remains to be clarified by clinical studies. Previous iv vivo studies have shown that turquoise light at wavelength about 490 nm is more efficacious than blue light at wavelength 460 nm, which is the golden standard in phototherapy treatment today. Though, previous studies used light tubes, today we use light emitting diodes (LED'S). The overall aim of this study was therefore to compare the efficacy of turquoise LED's versus blue LED's for decreasing total serum bilirubin in neonates with gestational age \> 33 weeks and uncomplicated hyperbilirubinemia.

Enrollment

90 patients

Sex

All

Ages

33+ weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newborns with gestational age >33 weeks and neonatal hyperbilirubinemia requiring treatment with phototherapy according to the national guidelines

Exclusion criteria

  • Haemolytic disease (Rhesus and Kell blood type isoimmunization, spherocytosis)
  • Liver disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

Blue light wavelenght 460 nm
Active Comparator group
Treatment:
Other: Phototherapy
Turquoise light wavelength 499 nm
Active Comparator group
Treatment:
Other: Phototherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems